Patent Ductus Arteriosus, Prematurity; Extreme
Conditions
Brief summary
Patent ductus arteriosus (PDA) is an important morbidity of that the diagnosis and treatment is controversy in premature infants. A number of scoring systems have been developed, including the findings of echocardiography on the diagnosis and treatment of PDA. This study aimed to develop a new clinical scoring system that will enable the rapid, standard and noninvasive evaluation of hemodynamically significant PDA earlier, without relying on echocardiographic findings in premature babies with extremely low birth weight, and to determine the role of this scoring system in early diagnosis and treatment.
Detailed description
This study aimed to develop a new clinical scoring system that will enable the rapid, standard and noninvasive evaluation of hemodynamically significant PDA earlier, without relying on echocardiographic findings in premature babies with extremely low birth weight, and to determine the role of this scoring system in early diagnosis and treatment.
Interventions
None listed
Sponsors
Kanuni Sultan Suleyman Training and Research Hospital
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
No minimum to 15 Days
Healthy volunteers
No
Inclusion criteria
* informed consent obtained from parents * extremely preterm infants * infants born before 28 gestational week
Exclusion criteria
* lack of informed consent * chromosomal abnormality * cardiovascular abnormality
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Number of Participants with Patent Ductus Arteriosus | 7 days | number of participants who diagnosed for hemodynamically significant PDA and had an elevated score of the newly developed system by us. |
Countries
Turkey (Türkiye)
Contacts
Primary ContactSeda Y Semerci
Backup ContactMerih Y Cetinkaya
Outcome results
None listed